Published in BMC Cancer on July 23, 2011
Open Versus Laparoscopically-assisted Esophagectomy for Cancer | NCT00937456
Current management of esophageal cancer. J Thorac Dis (2014) 1.36
Commentary on "Uttley L, Campbell F, Rhodes M et al. Minimally invasive esophagectomy versus open surgery: is there an advantage? Surg Endosc 2013;27(3):724-731". Surg Endosc (2013) 1.12
Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today (2012) 1.11
Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. Ann Thorac Surg (2016) 0.97
Oncological feasibility of laparoscopic distal pancreatectomy for adenocarcinoma: a single-institution comparative study. World J Surg (2014) 0.96
Superiority of Minimally Invasive Oesophagectomy in Reducing In-Hospital Mortality of Patients with Resectable Oesophageal Cancer: A Meta-Analysis. PLoS One (2015) 0.92
Esophageal surgery in minimally invasive era. World J Gastrointest Surg (2016) 0.82
Surgical treatments for esophageal cancers. Ann N Y Acad Sci (2014) 0.82
Laparoscopic approach to gastrointestinal malignancies: toward the future with caution. World J Gastroenterol (2014) 0.82
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial. BMC Cancer (2016) 0.77
Management of early-stage esophageal neoplasia (MESEN) consensus. World J Surg (2014) 0.77
Hybrid minimally invasive esophagectomy vs. open esophagectomy: a matched case analysis in 120 patients. Langenbecks Arch Surg (2017) 0.77
Outcomes of thoracoscopic esophagectomy in prone position with laparoscopic gastric mobilization for esophageal cancer. Langenbecks Arch Surg (2016) 0.76
Pros and cons of the gasless laparoscopic transhiatal esophagectomy for upper esophageal carcinoma. Surg Endosc (2015) 0.75
Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field). Ann Cardiothorac Surg (2017) 0.75
Total minimally invasive esophagectomy for esophageal cancer: approaches and outcomes. Langenbecks Arch Surg (2016) 0.75
Morbidity analysis in minimally invasive esophagectomy for oesophageal cancer versus conventional over the last 10 years, a single institution experience. J Minim Access Surg (2017) 0.75
Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. Surg Endosc (2012) 0.75
Discrepancy Between Clinical and Pathologic Nodal Status of Esophageal Cancer and Impact on Prognosis and Therapeutic Strategy. Ann Surg Oncol (2017) 0.75
Hybrid and total minimally invasive esophagectomy: how I do it. J Thorac Dis (2017) 0.75
Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery (1992) 8.98
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72
Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg (2007) 2.60
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol (2007) 2.07
Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg (2007) 1.98
Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg (2000) 1.71
Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surg (2011) 1.46
Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg (2008) 1.46
Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg (2007) 1.35
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer (2010) 1.30
Laparoscopic mobilization of the stomach for oesophageal replacement. Br J Surg (1996) 1.15
A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res (2004) 1.05
Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. J Am Coll Surg (2011) 0.99
Laparoscopic versus open gastroplasty in esophagectomy for esophageal cancer: a comparative study. Surg Laparosc Endosc Percutan Tech (2006) 0.89
Results of the combination of open transthoracic esophagectomy with laparoscopic gastric tube formation for esophageal cancer. Dig Surg (2006) 0.86
Minimally invasive esophagectomy for cancer: prospective evaluation of laparoscopic gastric mobilization. World J Surg (2006) 0.84
[Respiratory complications after oesophagectomy for cancer]. Rev Mal Respir (2008) 0.83
Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study. Surg Endosc (2005) 0.82
Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol (2005) 8.98
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 7.05
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol (2008) 6.45
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol (2007) 6.08
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96
Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg (2013) 2.70
Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology (2006) 2.62
External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg (2011) 2.60
Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer (2003) 2.23
Strategies in the prevention of the formation of postoperative adhesions in digestive surgery: a systematic review of the literature. Dis Colon Rectum (2014) 2.07
Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol (2007) 2.07
Surgical management of liver hydatid disease: subadventitial cystectomy versus resection of the protruding dome. World J Surg (2014) 2.04
Impact of age over 75 years on outcomes after pancreaticoduodenectomy. J Surg Res (2012) 2.00
Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg (2007) 1.97
Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother (2007) 1.96
Anastomotic leakage after elective right versus left colectomy for cancer: prevalence and independent risk factors. J Am Coll Surg (2007) 1.88
Synthesis and Characterization of New Chiral Schiff Base Complexes with Diiminobinaphthyl or Diiminocyclohexyl Moieties as Potential Enantioselective Epoxidation Catalysts. Inorg Chem (1996) 1.81
The antimalarial drug artemisinin alkylates heme in infected mice. Proc Natl Acad Sci U S A (2005) 1.81
Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg (2009) 1.70
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. J Pathol (2011) 1.69
Detection of BRAF p.V600E mutations in melanomas: comparison of four methods argues for sequential use of immunohistochemistry and pyrosequencing. J Mol Diagn (2012) 1.66
Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology (2003) 1.65
Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial. Ann Surg (2003) 1.65
A controlled randomized multicenter trial of pancreatogastrostomy or pancreatojejunostomy after pancreatoduodenectomy. Am J Surg (2005) 1.60
Laparoscopic versus open approach for solitary insulinoma. Surg Endosc (2006) 1.55
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol (2011) 1.54
Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg (2005) 1.54
Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas (2012) 1.53
Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg (2013) 1.50
Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy? Eur J Cardiothorac Surg (2005) 1.49
Anatomical variations of the hepatic artery: study of 932 cases in liver transplantation. Surg Radiol Anat (2006) 1.48
Risk factors for chronic pain after open ventral hernia repair by underlay mesh placement. World J Surg (2012) 1.47
Peng's binding pancreaticojejunostomy after pancreaticoduodenectomy: a French prospective study. J Gastrointest Surg (2010) 1.47
Airways colonizations in patients undergoing lung cancer surgery. Eur J Cardiothorac Surg (2011) 1.45
Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum (2005) 1.44
Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma. Chemotherapy (2010) 1.43
Molecular detection of microorganisms in distal airways of patients undergoing lung cancer surgery. Ann Thorac Surg (2011) 1.42
Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg (2008) 1.41
Survival end point reporting in randomized cancer clinical trials: a review of major journals. J Clin Oncol (2008) 1.41
From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc Chem Res (2002) 1.39
Bronchioloalveolar carcinoma: myths and realities in the surgical management. Eur J Cardiothorac Surg (2003) 1.39
A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med (2007) 1.39
Gemcitabine-induced severe pulmonary toxicity. Fundam Clin Pharmacol (2004) 1.33
Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg (2007) 1.33
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab (2012) 1.32
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer. Eur J Cancer (2012) 1.32
Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial. Arch Surg (2004) 1.30
Schistosomiasis chemotherapy. Angew Chem Int Ed Engl (2013) 1.29
Dendrimeric coating of glass slides for sensitive DNA microarrays analysis. Nucleic Acids Res (2003) 1.25
Totally laparoscopic right hepatectomy. Am J Surg (2007) 1.25
Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg (2007) 1.24
Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study. J Hepatol (2012) 1.21
High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg (2008) 1.21
Conservative vs restrictive individualized goal-directed fluid replacement strategy in major abdominal surgery: A prospective randomized trial. Arch Surg (2010) 1.21
Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg (2007) 1.21
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Respir Med (2004) 1.20
Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg (2003) 1.20
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist (2011) 1.20
Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer. Anticancer Drugs (2006) 1.19
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg (2004) 1.18
Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol (2012) 1.18
Selection of a trioxaquine as an antimalarial drug candidate. Proc Natl Acad Sci U S A (2008) 1.18
Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes (2008) 1.16
Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy. Chemistry (2008) 1.14
The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg (2011) 1.14
Risk factors for mortality in major digestive surgery in the elderly: a multicenter prospective study. Ann Surg (2011) 1.13
Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol (2010) 1.13
Porphyrin derivatives for telomere binding and telomerase inhibition. Chembiochem (2005) 1.13
Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology (2013) 1.11
Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother (2002) 1.11
A single-institution prospective study of laparoscopic pancreatic resection. Arch Surg (2008) 1.11
Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg (2008) 1.10
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Clin Cancer Res (2006) 1.09
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer. Radiother Oncol (2011) 1.09
Colon cancer mutation: prognosis/prediction--letter. Clin Cancer Res (2013) 1.08
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transplant (2005) 1.08
Gastric signet ring cell carcinoma: how to investigate its impact on survival. J Clin Oncol (2013) 1.08
Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association. HPB (Oxford) (2013) 1.08
A retrospective study of silicone stent placement for management of anastomotic airway complications in lung transplant recipients: short- and long-term outcomes. J Heart Lung Transplant (2010) 1.07
Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg (2005) 1.07
Suitability of surgically induced chronic reflux in rats for studying esophageal carcinogenesis. Ann Surg (2015) 1.07